2 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Corneal Ectasia: new trials by email Literature Review of Corneal Ectasia trials Research Report on Corneal Ectasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system, placebo: 0.0% riboflavin ophthalmic solution with the KXL system - Corneal Ectasia | Phase 3 | Withdrawn | Glaukos Corporation | 2012-07-01 | 2021-04-26 | |
| Corneal Crosslinking in Keratoconus and Corneal Ectasia Riboflavin, Placebo - Progressive Keratoconus, Corneal Ectasia | Phase 2 / Phase 3 | Withdrawn | Ohio State University | 2008-04-01 | 2017-04-20 |
Corneal Diseases (1) · Dilatation, Pathologic (1) · Keratoconus (1)
Eye Diseases (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1)
Riboflavin (2)
Glaukos Corporation (1) · Ohio State University (1)
United States (1)
Richard Keates, MD (1) · Vineeta Belanger (1)